DSpace Repository

EPIDEMIOLOGY, CLINICAL CHARACTERISTICS, AND VIROLOGIC FEATURES OF COVID-19 PATIENTS IN KAZAKHSTAN: A NATION-WIDE RETROSPECTIVE COHORT STUDY

Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.

Show simple item record

dc.contributor.author Yegorov, Sergey
dc.contributor.author Goremykina, Maiya
dc.contributor.author Ivanova, Raifa
dc.contributor.author Good, Sara V.
dc.contributor.author Babenko, Dmitriy
dc.contributor.author Shevtsov, Alexandr
dc.contributor.author MacDonald, Kelly S.
dc.contributor.author Zhunussov, Yersin
dc.date.accessioned 2022-02-16T11:35:11Z
dc.date.available 2022-02-16T11:35:11Z
dc.date.issued 2021-04-16
dc.identifier.citation Yegorov, S., Goremykina, M., Ivanova, R., Good, S. V., Babenko, D., Shevtsov, A., MacDonald, K. S., & Zhunussov, Y. (2021). Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study. The Lancet Regional Health - Europe, 4, 100096. https://doi.org/10.1016/j.lanepe.2021.100096 en_US
dc.identifier.uri http://nur.nu.edu.kz/handle/123456789/6051
dc.description.abstract Background: The earliest coronavirus disease-2019 (COVID-19) cases in Central Asia were announced in March 2020 by Kazakhstan. Despite the implementation of aggressive measures to curb infection spread, gaps remain in the understanding of the clinical and epidemiologic features of the regional pandemic. Methods: We did a retrospective, observational cohort study of patients with laboratory-confirmed COVID-19 hospitalized in Kazakhstan between February and April 2020. We compared demographic, clinical, labora tory and radiological data of patients with different COVID-19 severities on admission. Logistic regression was used to assess factors associated with disease severity and in-hospital death. Whole-genome SARS-CoV 2 analysis was performed in 53 patients. Findings: Of the 1072 patients with laboratory-confirmed COVID-19 in March-April 2020, the median age was 36 years (IQR 24 50) and 484 (45%) were male. On admission, 683 (64%) participants had asymptomatic/ mild, 341 (32%) moderate, and 47 (4%) severe-to-critical COVID-19 manifestation; 20 in-hospital deaths (1 87%) were reported by 5 May 2020. Multivariable regression indicated increasing odds of severe disease associated with older age (odds ratio 1 05, 95% CI 1 03-1 07, per year increase; p<0 001), the presence of comorbidities (2 34, 95% CI 1 18-4 85; p=0 017) and elevated white blood cell count (WBC, 1 13, 95% CI 1 00- 1 27; p=0 044) on admission, while older age (1 09, 95% CI 1 06-1 13, per year increase; p<0 001) and male sex (5 63, 95% CI 2 06-17 57; p=0 001) were associated with increased odds of in-hospital death. The SARS CoV-2 isolates grouped into seven phylogenetic lineages, O/B.4.1, S/A.2, S/B.1.1, G/B.1, GH/B.1.255, GH/B.1.3 and GR/B.1.1.10; 87% of the isolates were O and S sub-types descending from early Asian lineages, while the G, GH and GR isolates were related to lineages from Europe and the Americas. Interpretation: Older age, comorbidities, increased WBC count, and male sex were risk factors for COVID-19 disease severity and mortality in Kazakhstan. The broad SARS-CoV-2 diversity suggests multiple importa tions and community-level amplification predating travel restriction en_US
dc.language.iso en en_US
dc.publisher The Lancet Regional Health - Europe en_US
dc.rights Attribution-NonCommercial-ShareAlike 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/us/ *
dc.subject Type of access: Open Access en_US
dc.subject COVID-19 SARS-CoV-2 en_US
dc.subject Clinical characteristics en_US
dc.subject Disease risk factors en_US
dc.subject Molecular epidemiology en_US
dc.subject Central Asia en_US
dc.subject Kazakhstan en_US
dc.subject SARS-CoV-2 genomics en_US
dc.subject Disease severity en_US
dc.title EPIDEMIOLOGY, CLINICAL CHARACTERISTICS, AND VIROLOGIC FEATURES OF COVID-19 PATIENTS IN KAZAKHSTAN: A NATION-WIDE RETROSPECTIVE COHORT STUDY en_US
dc.type Article en_US
workflow.import.source science


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States